Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Academy of Medical Sciences of Zhengzhou University, Zhengzhou, Henan, China.
Oncoimmunology. 2023 May 24;12(1):2212532. doi: 10.1080/2162402X.2023.2212532. eCollection 2023.
Natural killer/T-cell lymphoma (NKTCL) is an incurable aggressive T-cell lymphoma closely correlated with Epstein‒Barr virus (EBV) infection. Chronic and consistent viral infection induces T-cell exhaustion. Herein, we describe T-cell dysfunction in NKTCL patients for the first time. Peripheral blood mononuclear cells (PBMCs) from age-matched healthy donors (HDs) and NKTCL patients were collected, and lymphocyte distributions, multiple surface inhibitory receptors (IRs), effector cytokine production and cell proliferation were determined by flow cytometry. PBMCs from HDs were cocultured with NKTCL cell lines to verify the clinical findings. IR expression was further assessed in NKTCL tumor biopsies using multiplex immunohistochemistry (mIHC). NKTCL patients have higher frequencies than HDs of inhibitory T regulatory cells (Tregs) and myeloid-derived suppressor cells (MDSCs). T-cell distribution also varies between NKTCL patients and HDs. T cells from NKTCL patients demonstrated higher expression levels of multiple IRs than HDs. Meanwhile, T-cell proliferation and interferon-γ production was significantly reduced in NKTCL patients. More importantly, the number of EBV-specific cytotoxic cells was lower in NTKCL patients, and these cells demonstrated upregulation of multiple IRs and secreted fewer effector cytokines. Interestingly, NKTCL cells caused normal PBMCs to acquire T-cell exhaustion phenotypes and induced generation of Tregs and MDSCs. In line with ex vivo finding, mIHC results showed that CD8+ T cells from NKTCL tumor biopsies expressed much higher level of IRs compared with reactive lymphoid hyperplasia individuals. The immune microenvironment of NKTCL patients exhibited T-cell dysfunction and accumulation of inhibitory cell components, which may contribute to impaired antitumor immunity.
自然杀伤细胞/T 细胞淋巴瘤(NKTCL)是一种无法治愈的侵袭性 T 细胞淋巴瘤,与 Epstein-Barr 病毒(EBV)感染密切相关。慢性和持续的病毒感染可诱导 T 细胞衰竭。在此,我们首次描述了 NKTCL 患者的 T 细胞功能障碍。收集年龄匹配的健康供体(HDs)和 NKTCL 患者的外周血单个核细胞(PBMCs),并通过流式细胞术测定淋巴细胞分布、多种表面抑制性受体(IR)、效应细胞因子产生和细胞增殖。将 HDs 的 PBMCs 与 NKTCL 细胞系共培养以验证临床发现。使用多重免疫组化(mIHC)进一步评估 NKTCL 肿瘤活检中的 IR 表达。NKTCL 患者的抑制性 T 调节细胞(Tregs)和髓源抑制细胞(MDSCs)频率高于 HDs。T 细胞分布也在 NKTCL 患者和 HDs 之间存在差异。与 HDs 相比,NKTCL 患者的 T 细胞表现出多种 IR 更高的表达水平。同时,NKTCL 患者的 T 细胞增殖和干扰素-γ产生显著降低。更重要的是,NKTCL 患者的 EBV 特异性细胞毒性细胞数量较低,这些细胞表现出多种 IR 的上调和效应细胞因子分泌减少。有趣的是,NKTCL 细胞导致正常 PBMCs 获得 T 细胞衰竭表型,并诱导 Tregs 和 MDSCs 的产生。与体外发现一致,mIHC 结果显示,与反应性淋巴组织增生个体相比,NKTCL 肿瘤活检中的 CD8+T 细胞表达的 IR 水平要高得多。NKTCL 患者的免疫微环境表现出 T 细胞功能障碍和抑制性细胞成分的积累,这可能导致抗肿瘤免疫受损。